Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19

NCT04912921 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

115

Enrollment

OTHER

Sponsor class

Conditions

Inflammation
COVID19

Interventions

DIETARY_SUPPLEMENT: palmitoylethanolamide
DIETARY_SUPPLEMENT: Placebo
DIETARY_SUPPLEMENT: Curcumin
DIETARY_SUPPLEMENT: Control (microcrystalline cellulose)

Sponsor

Arizona State University